Zai Lab Limited (HKG:9688)
15.48
+0.68 (4.59%)
At close: Mar 6, 2026
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 17.13 billion as of March 6, 2026. Its market cap has decreased by -34.75% in one year.
Market Cap
17.13B
Enterprise Value
13.49B
Revenue
3.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
15.48
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 17.13B, an increase of 1,160.57%. That is a compound annual growth rate of 34.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.13B | 12.16% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 25.69B |
| Genscript Biotech | 23.70B |
| TransThera Sciences (Nanjing) | 23.44B |
| PegBio | 23.43B |
| InnoCare Pharma | 22.09B |
| Ascentage Pharma Group International | 15.27B |
| Ascletis Pharma | 15.07B |
| Keymed Biosciences | 14.14B |